Age
Item
1. patient is ≥18 years old.
boolean
C0001779 (UMLS CUI [1])
Percutaneous Coronary Intervention
Item
2. eligible for percutaneous coronary intervention (pci)
boolean
C1532338 (UMLS CUI [1])
Stable angina | Angina, Unstable | Ischemia | Silent myocardial ischemia
Item
3. documented stable angina pectoris or unstable angina pectoris with documented ischemia or documented silent ischemia
boolean
C0340288 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0022116 (UMLS CUI [3])
C0340291 (UMLS CUI [4])
Left ventricular ejection fraction
Item
4. left ventricular ejection fraction (lvef) of >/=25%
boolean
C0428772 (UMLS CUI [1])
Indication Coronary Artery Bypass Surgery
Item
5. acceptable candidate for coronary artery bypass grafting (cabg)
boolean
C3146298 (UMLS CUI [1,1])
C0010055 (UMLS CUI [1,2])
Informed Consent | Informed Consent Legal Guardian
Item
6. patient or legal guardian understands the study requirements and the treatment procedures and provides written informed consent before any study-specific tests or procedures are performed
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0023226 (UMLS CUI [2,2])
Follow-up Evaluation Compliance behavior
Item
7. willing to comply with all specified follow-up evaluations
boolean
C3274571 (UMLS CUI [1,1])
C0220825 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Inclusion criteria angiography
Item
angiographic inclusion criteria:
boolean
C1512693 (UMLS CUI [1,1])
C0002978 (UMLS CUI [1,2])
Therapeutic procedure Target Lesion Stent | Therapeutic procedure Lesion Bare metal stent | Insertion of drug-coated stent(s), i.e. heparin coated
Item
1. only one lesion (target lesion) may be treated with the study stent. however, one additional lesion in a non-target vessel may be treated during the index procedure with a commercially available bare metal stent, heparin-coated stent or taxus express stent.
boolean
C0087111 (UMLS CUI [1,1])
C2986546 (UMLS CUI [1,2])
C0038257 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0221198 (UMLS CUI [2,2])
C2825200 (UMLS CUI [2,3])
C1135499 (UMLS CUI [3])
Therapeutic procedure Target Lesion | Therapeutic procedure Multiple lesions Covered Stent One
Item
2. target lesion enrolled for treatment may be composed of multiple lesions (not more than 10mm between diseased segments)but must be completely covered by one study stent.
boolean
C0087111 (UMLS CUI [1,1])
C2986546 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0577305 (UMLS CUI [2,2])
C0439844 (UMLS CUI [2,3])
C0038257 (UMLS CUI [2,4])
C0205447 (UMLS CUI [2,5])
Target Lesion Location Within Coronary artery Native Single
Item
3. target lesion located within a single native coronary artery
boolean
C2986546 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0332285 (UMLS CUI [1,3])
C0205042 (UMLS CUI [1,4])
C0302891 (UMLS CUI [1,5])
C0205171 (UMLS CUI [1,6])
Target Lesion Cumulative Length | Visual estimation
Item
4. cumulative target lesion length is ≥10 mm and ≤28 mm (visual estimate)
boolean
C2986546 (UMLS CUI [1,1])
C1511559 (UMLS CUI [1,2])
C1444754 (UMLS CUI [1,3])
C0444684 (UMLS CUI [2])
Reference Vessel Diameter | Visual estimation
Item
5. rvd of ≥2.5 mm to ≤4.0 mm (visual estimate)
boolean
C1706462 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C1301886 (UMLS CUI [1,3])
C0444684 (UMLS CUI [2])
Target Lesion Diameter Stenosis Percentage | Visual estimation
Item
6. target lesion diameter stenosis ≥50% (visual estimate)
boolean
C2986546 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C0678234 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0444684 (UMLS CUI [2])
Target Lesion Coronary de novo
Item
7. target lesion is de novo (i.e., a coronary lesion not previously treated)
boolean
C2986546 (UMLS CUI [1,1])
C1522318 (UMLS CUI [1,2])
C1515568 (UMLS CUI [1,3])
Exclusion Criteria General
Item
general exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C0205246 (UMLS CUI [1,2])
Hypersensitivity Paclitaxel
Item
1. known hypersensitivity to paclitaxel
boolean
C0020517 (UMLS CUI [1,1])
C0144576 (UMLS CUI [1,2])
Therapeutic procedure Drug-Coated Stent Coronary Against Restenosis | Therapeutic procedure Drug-Eluting Coronary Stent Against Restenosis
Item
2. any previous, concurrent or planned treatment with a non-study anti-restenotic drug-coated or drug-eluting coronary stent.
boolean
C0087111 (UMLS CUI [1,1])
C1445093 (UMLS CUI [1,2])
C1522318 (UMLS CUI [1,3])
C0521124 (UMLS CUI [1,4])
C0333186 (UMLS CUI [1,5])
C0087111 (UMLS CUI [2,1])
C1262327 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0333186 (UMLS CUI [2,4])
Therapeutic procedure Target vessel Stent Investigational | Therapeutic procedure Target vessel Stent commercial
Item
3. previous or planned use of both the study stent and a non-study stent (i.e., commercial stent) in the treatment of the target vessel
boolean
C0087111 (UMLS CUI [1,1])
C0449618 (UMLS CUI [1,2])
C0038257 (UMLS CUI [1,3])
C1517586 (UMLS CUI [1,4])
C0087111 (UMLS CUI [2,1])
C0449618 (UMLS CUI [2,2])
C0038257 (UMLS CUI [2,3])
C0680536 (UMLS CUI [2,4])
intravascular brachytherapy Target vessel
Item
4. previous or planned treatment with intravascular brachytherapy in the target vessel
boolean
C0994608 (UMLS CUI [1,1])
C0449618 (UMLS CUI [1,2])
Coronary Artery Bypass Surgery Planned
Item
5. planned cabg ≤9-months post-index procedure
boolean
C0010055 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Myocardial Infarction | Creatine kinase measurement | Creatine kinase MB measurement
Item
6. mi within 72 hours prior to the index procedure and or creatine kinase(ck) >2x the local laboratory's uln unless ck-mb is <2x uln.
boolean
C0027051 (UMLS CUI [1])
C0201973 (UMLS CUI [2])
C0523584 (UMLS CUI [3])
Cerebrovascular accident
Item
7. cerebrovascular accident (cva) within the past 6 months
boolean
C0038454 (UMLS CUI [1])
Shock, Cardiogenic
Item
8. cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
Renal dysfunction | Renal dysfunction chronic
Item
9. acute or chronic renal dysfunction
boolean
C3279454 (UMLS CUI [1])
C3279454 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Medical contraindication Aspirin | Medical contraindication clopidogrel | Medical contraindication Ticlopidine
Item
10. contraindication to asa, or to both clopidogrel and ticlopidine
boolean
C1301624 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0040207 (UMLS CUI [3,2])
Leukopenia
Item
11. leukopenia
boolean
C0023530 (UMLS CUI [1])
Thrombocytopenia Thrombocytosis
Item
12. thrombocytopenia or thrombocytosis
boolean
C0040034 (UMLS CUI [1,1])
C0836924 (UMLS CUI [1,2])
Peptic Ulcer | Gastrointestinal Hemorrhage
Item
13. active peptic ulcer or active gastrointestinal (gi) bleeding
boolean
C0030920 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
Hypersensitivity Stainless Steel
Item
14. known allergy to stainless steel
boolean
C0020517 (UMLS CUI [1,1])
C0038126 (UMLS CUI [1,2])
anaphylaxis Contrast Media
Item
15. any prior true anaphylactic reaction to contrast agents
boolean
C0002792 (UMLS CUI [1,1])
C0009924 (UMLS CUI [1,2])
Paclitaxel | Chemotherapeutic agent
Item
16. patient is currently, or has been treated with paclitaxel or other chemotherapeutic agents within 12-months of the index procedure
boolean
C0144576 (UMLS CUI [1])
C0729502 (UMLS CUI [2])
Paclitaxel Anticipated | Sirolimus Oral Anticipated
Item
17. anticipated treatment with paclitaxel or oral rapamycin during any period in the 9-months after the index procedure
boolean
C0144576 (UMLS CUI [1,1])
C3840775 (UMLS CUI [1,2])
C0072980 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C3840775 (UMLS CUI [2,3])
Gender Reproduction intent
Item
18. male or female with known intention to procreate within 3 months after the index procedure
boolean
C0079399 (UMLS CUI [1,1])
C0035150 (UMLS CUI [1,2])
C1283828 (UMLS CUI [1,3])
Childbearing Potential Pregnancy test positive | Breast Feeding | Pregnancy, Planned
Item
19. female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the study.
boolean
C3831118 (UMLS CUI [1,1])
C0240802 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Life Expectancy Duration Due to Other medical condition
Item
20. life expectancy of less than 24-months due to other medical condition
boolean
C0023671 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C3843040 (UMLS CUI [1,4])
Comorbidity Study Subject Participation Status Limited | Comorbidity Protocol Compliance Limited | Comorbidity Interferes with research results
Item
21. co-morbid condition(s) that could limit the patient's ability to participate in the study, compliance with follow-up requirements or impact the scientific integrity of the study
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C0525058 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
22. currently participating in another investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the endpoints of this study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Exclusion Criteria angiography
Item
angiographic exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C0002978 (UMLS CUI [1,2])
Left main coronary artery disease | Stenosis Percentage
Item
1. left main coronary artery disease (stenosis >50%) whether protected or unprotected
boolean
C1299433 (UMLS CUI [1])
C0678234 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
Target Lesion Location Ostium | Target Lesion Distance Vessel origin
Item
2. target lesion is ostial in location (within 3.0 mm of vessel origin)
boolean
C2986546 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0444567 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C0012751 (UMLS CUI [2,2])
C1301415 (UMLS CUI [2,3])
Target Lesion Calcified Moderate | Target Lesion Calcified Severe | Target vessel Proximal Calcified Moderate | Target vessel Proxima Calcified Severe
Item
3. target lesion and/or target vessel proximal to the target lesion is moderately or severely calcified by visual estimate.
boolean
C2986546 (UMLS CUI [1,1])
C0175895 (UMLS CUI [1,2])
C0205081 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C0175895 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0449618 (UMLS CUI [3,1])
C0205107 (UMLS CUI [3,2])
C0175895 (UMLS CUI [3,3])
C0205081 (UMLS CUI [3,4])
C0449618 (UMLS CUI [4,1])
C0205107 (UMLS CUI [4,2])
C0175895 (UMLS CUI [4,3])
C0205082 (UMLS CUI [4,4])
Target Lesion Tortuous | Target vessel Proximal Tortuous
Item
4. target lesion and/or target vessel proximal to the target lesion is tortuous.
boolean
C2986546 (UMLS CUI [1,1])
C4068863 (UMLS CUI [1,2])
C0449618 (UMLS CUI [2,1])
C0205107 (UMLS CUI [2,2])
C4068863 (UMLS CUI [2,3])
Target Lesion Location Related Vessel
Item
5. target lesion is located within or distal to a >60 degree bend in the vessel
boolean
C2986546 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0005847 (UMLS CUI [1,4])
Target Lesion Involvement with Coronary Vessel Bifurcation Lesion Diameter
Item
6. target lesion involves a bifurcation with a side branch vessel >2.0 mm in diameter.
boolean
C2986546 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C3640041 (UMLS CUI [1,3])
C1301886 (UMLS CUI [1,4])
Target Lesion Occluded Total | TIMI grade 0: no perfusion | TIMI grade 1: penetration without perfusion
Item
7. target lesion is totally occluded (timi flow </= 1), either at baseline or predilation
boolean
C2986546 (UMLS CUI [1,1])
C1947917 (UMLS CUI [1,2])
C0439810 (UMLS CUI [1,3])
C1299341 (UMLS CUI [2])
C1299340 (UMLS CUI [3])
Definite thrombus | Thrombus Probable | angiography
Item
8. angiographic presence of probable or definite thrombus
boolean
C1298826 (UMLS CUI [1])
C0087086 (UMLS CUI [2,1])
C0033204 (UMLS CUI [2,2])
C0002978 (UMLS CUI [3])
Target vessel Pretreatment Medical Device Illicit
Item
9. pre-treatment of the target vessel is not allowed with any device
boolean
C0449618 (UMLS CUI [1,1])
C3539076 (UMLS CUI [1,2])
C0025080 (UMLS CUI [1,3])
C0332266 (UMLS CUI [1,4])